Printer Friendly

MEDIVATORS, INC. REPORTS FOURTH QUARTER AND YEAR-END RESULTS

 CANNON FALLS, Minn., March 19 /PRNewswire/ -- MediVators, Inc. (NASDAQ: MVAT) announced sales for the fourth quarter in the year ended Dec. 31, 1992 increased 85 percent to $673,041 from $363,730 in the comparable 1991 quarter. The company generated a net loss of $273,034 or $.09 per share for the fourth quarter of 1992 versus a net loss of $25,037 or $.02 per share in the 1991 fourth quarter. For the year ended Dec. 31, 1992 sales were $2,013,703 which produced a net loss of $1,058,979 or $.37 per share compared to sales of $1,608,373 and net income of $28,979 or $.02 per share in 1991.
 The increase in sales for the fourth quarter and year ended Dec. 31, 1992 was primarily due to sales of DSD-91 disinfector kits into foreign markets and the continued expansion of MedFab, the company's custom plastic machining and assembly business. Gross profit decreased as a percentage of sales due to lower margins on the DSD-91 units and MedFab's operations. For the fourth quarter and the year ended Dec. 31, 1992, the net loss was attributed to increased general and administrative expenses, start up losses of MedFab, expenditures relating to the redesign of DSI's sharps disposal system and research and development expenses relating to MediFlex's articulation technology licensed from Stanford University.
 Donald L. Sturtevant, president, added that "On March 8, 1993, the FDA requested additional information regarding the pending DSD-91 510(k). The company is preparing a response to be filed within 30 days."
 MediVators designs, manufactures and markets endoscopic disinfection and medical waste disposable equipment and supplies. DSI is a wholly owned subsidiary that manufactures and markets a sharps disposal system. MediFlex is an 80 percent own subsidiary that is developing applications of articulation technology licensed from Stanford University.
 MEDIVATORS, INC.
 Condensed Statements of Operations
 (Unaudited)
 Quarter Ended 12 Months Ended
 12/31/92 12/31/91 12/31/92 12/31/91
 Sales $673,041 $363,730 $2,013,703 $1,608,373
 Cost of sales 283,508 150,725 1,123,741 686,490
 Gross profit 389,533 213,005 889,962 921,883
 SG&A 540,444 283,131 1,721,679 907,643
 R&D 149,584 3,252 332,291 23,340
 Interest (income)
 expense, net (10,068) (48,341) (87,636) (38,079)
 Minority interest in sub (17,393) 0 (17,393) 0
 -- 662,567 238,042 1,948,941 892,904
 Income (loss)
 before taxes (273,034) (25,037) (1,058,979) 28,979
 Provision for taxes 0 0 0 3,500
 -- (273,034) (25,037) (1,058,979) 25,479
 Extraordinary item --
 tax benefit of NOL 0 0 0 3,500
 Net income (loss) $(273,034) $(25,037)$(1,058,979) $28,979
 Net income (loss)
 per share $(0.09) $(0.02) $(0.37) $0.02
 Weighted average common
 shares outstanding 2,845,804 1,505,650 2,845,804 1,505,650
 -0- 3/19/93
 /CONTACT: Curtis D. Luebke, chairman of the board, or Donald L. Sturtevant, president and CEO, 507-263-4721, both of MediVators/
 (MVAT)


CO: MediVators, Inc. ST: Minnesota IN: MTC SU: ERN

AL -- MN012 -- 7981 03/19/93 15:28 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 19, 1993
Words:539
Previous Article:TEMPLETON GLOBAL GOVERNMENTS INCOME TRUST ANNOUNCES MONTHLY DIVIDEND
Next Article:CITIZENS CORPORATION MAKES INITIAL PUBLIC OFFERING OF 6,250,000 SHARES OF COMMON STOCK AT $24.00 PER SHARE
Topics:


Related Articles
MEDIVATORS ANNOUNCES 1991 FOURTH QUARTER RESULTS
MEDIVATORS REPORTS FIRST QUARTER SALES
MEDIVATORS REPORTS THIRD QUARTER
MEDIVATORS REPORTS RESULTS
MEDIVATORS, INC. REPORTS FIRST QUARTER RESULTS
MEDIVATORS, INC. REPORTS SECOND QUARTER RESULTS
MEDIVATORS, INC. REPORTS RESULTS
MEDIVATORS ANNOUNCES RESULTS
Cantel Industries, Inc. Announces Earnings of $.10 Per Share for the Quarter vs. Prior Year Loss of $.23 Per Share
Cantel Industries, Inc. Announces Earnings of $.10 Per Share for the Quarter vs. Prior Year Loss of $.23 Per Share

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters